News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
323,068 Results
Type
Article (17569)
Company Profile (295)
Press Release (305195)
Multimedia
Podcasts (71)
Webinars (13)
Section
Business (95280)
Career Advice (211)
Deals (16763)
Drug Delivery (46)
Drug Development (57177)
Employer Resources (40)
FDA (6780)
Job Trends (6449)
News (171114)
Policy (11984)
Tag
Academia (995)
Accelerated approval (9)
Adcomms (14)
Allergies (67)
Alliances (24658)
ALS (103)
Alzheimer's disease (1040)
Antibody-drug conjugate (ADC) (151)
Approvals (6861)
Artificial intelligence (195)
Autoimmune disease (39)
Automation (8)
Bankruptcy (121)
Best Places to Work (5559)
BIOSECURE Act (7)
Biosimilars (80)
Biotechnology (239)
Bladder cancer (87)
Brain cancer (33)
Breast cancer (265)
Cancer (2451)
Cardiovascular disease (192)
Career advice (188)
Career pathing (5)
CAR-T (180)
CDC (5)
Cell therapy (472)
Cervical cancer (15)
Clinical research (47835)
Collaboration (870)
Company closure (3)
Compensation (524)
Complete response letters (27)
COVID-19 (1209)
CRISPR (72)
C-suite (342)
Cystic fibrosis (106)
Data (2821)
Decentralized trials (1)
Denatured (13)
Depression (63)
Diabetes (226)
Diagnostics (2048)
Digital health (6)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (137)
Drug pricing (44)
Drug shortages (5)
Duchenne muscular dystrophy (166)
Earnings (39578)
Editorial (22)
Employer branding (8)
Employer resources (37)
Events (59000)
Executive appointments (618)
FDA (8142)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (755)
Gene editing (149)
Generative AI (15)
Gene therapy (382)
GLP-1 (547)
Government (1270)
Grass and pollen (2)
Guidances (195)
Healthcare (7733)
HIV (23)
Huntington's disease (31)
IgA nephropathy (50)
Immunology and inflammation (154)
Immuno-oncology (8)
Indications (32)
Infectious disease (1309)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (34)
Intellectual property (116)
Interviews (23)
IPO (9020)
IRA (21)
Job creations (1228)
Job search strategy (173)
Kidney cancer (8)
Labor market (19)
Layoffs (346)
Leadership (8)
Legal (1728)
Liver cancer (52)
Longevity (8)
Lung cancer (361)
Lymphoma (191)
Machine learning (15)
Management (10)
Manufacturing (276)
MASH (98)
Medical device (3184)
Medtech (3190)
Mergers & acquisitions (8296)
Metabolic disorders (636)
Multiple sclerosis (87)
NASH (14)
Neurodegenerative disease (127)
Neuropsychiatric disorders (40)
Neuroscience (1709)
NextGen: Class of 2025 (2313)
Non-profit (982)
Now hiring (26)
Obesity (308)
Opinion (136)
Ovarian cancer (99)
Pain (76)
Pancreatic cancer (107)
Parkinson's disease (169)
Partnered (11)
Patents (248)
Patient recruitment (186)
Peanut (41)
People (29989)
Pharmaceutical (52)
Pharmacy benefit managers (6)
Phase I (16505)
Phase II (22084)
Phase III (14576)
Pipeline (1896)
Policy (91)
Postmarket research (960)
Preclinical (6847)
Press Release (32)
Prostate cancer (110)
Psychedelics (45)
Radiopharmaceuticals (254)
Rare diseases (444)
Real estate (1763)
Recruiting (16)
Regulatory (10797)
Reports (20)
Research institute (1028)
Resumes & cover letters (24)
Rett syndrome (9)
RNA editing (15)
RSV (21)
Schizophrenia (101)
Series A (138)
Series B (99)
Service/supplier (2)
Sickle cell disease (64)
Special edition (15)
Spinal muscular atrophy (122)
Sponsored (14)
Startups (2225)
State (1)
Stomach cancer (5)
Supply chain (34)
Tariffs (24)
The Weekly (57)
Vaccines (407)
Venture capital (51)
Weight loss (173)
Women's health (26)
Worklife (2)
Date
Last 7 days (330)
Last 30 days (1485)
Last 365 days (21509)
2025 (14836)
2024 (23719)
2023 (26007)
2022 (31456)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (199)
Alabama (59)
Alaska (2)
Arizona (69)
Arkansas (5)
Asia (21319)
Australia (3659)
California (6159)
Canada (1647)
China (623)
Colorado (203)
Connecticut (247)
Delaware (175)
Europe (46658)
Florida (749)
Georgia (192)
Hawaii (2)
Idaho (18)
Illinois (337)
India (21)
Indiana (165)
Iowa (8)
Japan (186)
Kansas (72)
Kentucky (6)
Louisiana (4)
Maine (11)
Maryland (703)
Massachusetts (4836)
Michigan (99)
Minnesota (211)
Mississippi (3)
Missouri (36)
Montana (16)
Nebraska (4)
Nevada (32)
New Hampshire (15)
New Jersey (1623)
New Mexico (15)
New York (1606)
North Carolina (748)
North Dakota (6)
Northern California (2889)
Ohio (151)
Oklahoma (10)
Oregon (22)
Pennsylvania (1101)
Puerto Rico (9)
Rhode Island (25)
South America (274)
South Carolina (8)
Southern California (2338)
Tennessee (38)
Texas (790)
United States (20711)
Utah (105)
Virginia (131)
Washington D.C. (43)
Washington State (495)
West Virginia (1)
Wisconsin (56)
323,068 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Lupus Reveal Gives Investors a Peek at Biogen’s ‘Underappreciated’ Pipeline
With two late-stage programs set to read out in the next 48 months, Biogen is translating its wealth of experience in multiple sclerosis to lupus—developing a pipeline BMO Capital Markets analysts called “thoughtful.”
September 9, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
August 15, 2025
·
16 min read
Business
5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development
The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can be a goldmine for smaller companies. But it also has a unique set of challenges.
August 20, 2025
·
10 min read
·
Tristan Manalac
Press Releases
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
August 12, 2025
·
14 min read
Press Releases
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline
August 7, 2025
·
5 min read
Press Releases
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
September 11, 2025
·
5 min read
Press Releases
Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry
August 29, 2025
·
5 min read
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
August 12, 2025
·
13 min read
Press Releases
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
August 14, 2025
·
9 min read
Rare diseases
Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions
More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia since last year—are managing two products on the market and a pipeline estimated to be worth an additional $12 billion in sales.
July 15, 2025
·
5 min read
·
Heather McKenzie
1 of 32,307
Next
